0001214659-21-005571.txt : 20210517
0001214659-21-005571.hdr.sgml : 20210517
20210517160125
ACCESSION NUMBER: 0001214659-21-005571
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210331
FILED AS OF DATE: 20210517
DATE AS OF CHANGE: 20210517
EFFECTIVENESS DATE: 20210517
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Octagon Capital Advisors LP
CENTRAL INDEX KEY: 0001839435
IRS NUMBER: 843576791
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20958
FILM NUMBER: 21930175
BUSINESS ADDRESS:
STREET 1: 654 MADISON AVENUE
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
BUSINESS PHONE: 212-369-2829
MAIL ADDRESS:
STREET 1: 654 MADISON AVENUE
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001839435
XXXXXXXX
03-31-2021
03-31-2021
false
Octagon Capital Advisors LP
654 MADISON AVENUE
16TH FLOOR
NEW YORK
NY
10065
13F HOLDINGS REPORT
028-20958
N
Justin Hirsch
Chief Compliance Officer and Chief Financial Officer
212-369-2829
/s/ Justin Hirsch
New York
NY
05-17-2021
0
28
265477
INFORMATION TABLE
2
infotable.xml
4D MOLECULAR THERAPEUTICS IN
COM
35104E100
16410
378288
SH
SOLE
378288
0
0
ACCELERON PHARMA INC
COM
00434H108
15238
112363
SH
SOLE
112363
0
0
APELLIS PHARMACEUTICALS INC
COM
03753U106
23531
548374
SH
SOLE
548374
0
0
ARCUS BIOSCIENCES INC
COM
03969F109
11232
400000
SH
SOLE
400000
0
0
ARVINAS INC
COM
04335A105
11799
178500
SH
SOLE
178500
0
0
AVIDITY BIOSCIENCES INC
COM
05370A108
9741
446641
SH
SOLE
446641
0
0
CARDIFF ONCOLOGY INC
COM
14147L108
6019
650000
SH
SOLE
650000
0
0
CELLDEX THERAPEUTICS INC NEW
COM NEW
15117B202
11565
561398
SH
SOLE
561398
0
0
CHEMOCENTRYX INC
COM
16383L106
7690
150076
SH
SOLE
150076
0
0
CONNECT BIOPHARMA HLDGS LTD
ADS
207523101
6910
373492
SH
SOLE
373492
0
0
CURIS INC
COM NEW
231269200
24093
2128400
SH
SOLE
2128400
0
0
DESIGN THERAPEUTICS INC
COM
25056L103
7475
250000
SH
SOLE
250000
0
0
DYNE THERAPEUTICS INC
COM
26818M108
9064
583649
SH
SOLE
583649
0
0
EDGEWISE THERAPEUTICS INC
COM
28036F105
4063
125000
SH
SOLE
125000
0
0
FOGHORN THERAPEUTICS INC
COM
344174107
911
69132
SH
SOLE
69132
0
0
GOSSAMER BIO INC
COM
38341P102
13072
1413138
SH
SOLE
1413138
0
0
HELIX ACQUISITION CORP
COM CL A
G4444C102
4080
400000
SH
SOLE
400000
0
0
I MAB
SPONSORED ADS
44975P103
25692
530050
SH
SOLE
530050
0
0
IKENA ONCOLOGY INC
COM
45175G108
11300
400000
SH
SOLE
400000
0
0
IVERIC BIO INC
COM
46583P102
4203
680036
SH
SOLE
680036
0
0
JIYA ACQUISITION CORP
COM CL A
47760M102
2952
300000
SH
SOLE
300000
0
0
KRONOS BIO INC
COM
50107A104
4278
146173
SH
SOLE
146173
0
0
MERUS N V
COM
N5749R100
4178
200000
SH
SOLE
200000
0
0
NGM BIOPHARMACEUTICALS INC
COM
62921N105
5814
200000
SH
SOLE
200000
0
0
PMV PHARMACEUTICALS INC
COM
69353Y103
8223
250000
SH
SOLE
250000
0
0
PROMETHEUS BIOSCIENCES INC
COM
74349U108
3652
200000
SH
SOLE
200000
0
0
REVOLUTION MEDICINES INC
COM
76155X100
5787
126136
SH
SOLE
126136
0
0
TAYSHA GENE THERAPIES INC
COM SHS
877619106
6505
320440
SH
SOLE
320440
0
0